1 – 3 of 3
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma
(
- Contribution to journal › Article
- 2016
-
Mark
IL-33 is related to innate immune activation and sensitization to HDM in mild steroid-free asthma.
(
- Contribution to journal › Article
- 2013
-
Mark
Cultured Mast Cells from Patients with Asthma and Controls Respond with Similar Sensitivity to Recombinant Der P2-Induced, IgE-Mediated Activation
(
- Contribution to journal › Article